Podcasts about cancer screenings

The Future of Medicine Podcast, where we believe in promoting overall health and prevention over just treating sickness. Join us for the latest in medical advancements and expert advice. Subscribe and explore: https://youtube.com/@BrentwoodMD Last time Dr. Natalie Spradlin joined me on the podcast, we talked about the moments right after a patient finds out they might have cancer. We covered important topics like protecting your mental energy, getting a second opinion, and how to walk into that first oncology appointment as prepared as possible. If you missed it, When You Hear the Word “Cancer” is worth a read. As an assistant professor of hematology and oncology at Vanderbilt-Ingram Cancer Center, a co-director of Vanderbilt's Internal Medicine Miller Society, and a board-certified hematologist and oncologist with more than 14 years of clinical experience, Dr. Spradlin brings a unique perspective to topics that weigh on many people's minds. In our latest discussion, we take a look at evidence-backed ways to reduce cancer risk and detect cancer early, as well as the major types of cancer treatments and the role of clinical trials if you do receive a cancer diagnosis. Chapters (00:00:01) - Interview(00:01:41) - Lifestyle risk factors to prevent cancer(00:04:41) - Cancer Screening and Genetic Testing(00:10:11) - Wonders of the World: Whole Body MRIs(00:16:02) - AI in breast cancer diagnostics(00:19:13) - Talking About Cancer Therapeutics(00:19:51) - Treatment of cancer with three modalities(00:26:41) - Immunity Therapy: What is it?(00:30:08) - Clinical Trials(00:35:30) - Phase 1 cancer trials(00:38:35) - Screening for colorectal cancer options(00:41:07) - How to connect with your doctor about cancer at Vanderbilt(00:41:57) - Brentwood MD: A Celebration of the Podcast

This is a free preview of a paid episode. To hear more, visit sciencefictionspod.substack.comIt seems like the most obvious thing in the world: if you do more cancer screening, you'll catch tumours early and people will be better off. Former Top Gear presenter and current farmer Jeremy Clarkson recently went viral for saying exactly this about prostate cancer—in fact, he said you should lie to your doctor just to get the test.But it's not quite as straightforward. In this paid-only episode, we look at how strong the evidence is for universal screening for prostate cancer, breast cancer, and more. Oh, and guess what? Tom takes the opportunity to talk about Bayesianism again.

John talks with Dr. Peter Michalos about how artificial intelligence and advanced imaging are revolutionizing modern medicine by enabling the early detection of cancers.

Prostate cancer is the most commonly diagnosed cancer among men in Europe, and momentum is growing behind organised screening programmes that use prostate-specific antigen (PSA) testing alongside risk stratification and MRI to improve the balance between benefits and harms. However, introducing a screening programme requires more than clinical expertise. Health systems must also have the infrastructure, data systems, quality assurance mechanisms, and follow-up pathways needed to support effective implementation. In this episode, Dr Arunah Chandran joins eClinicalMedicine Senior Editor Sundus Ahmad to discuss a new study from the PRAISE-U (PRostate cancer Awareness and Initiative for Screening in the European Union) project. Drawing on readiness assessments across five pilot sites in Lithuania, Poland, Spain, and Ireland, the study evaluates whether health systems are prepared to deliver organised, risk-stratified prostate cancer screening. Together, they explore why strong clinical capacity alone may not be enough, highlighting gaps in invitation systems, counselling, quality assurance, data management, and long-term follow-up. This conversation examines what is needed to move from opportunistic testing to population-based screening and what lessons these findings offer for the future of prostate cancer early detection in Europe. Click here to read the full papers: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00601-1/fulltext https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(26)00346-9/fulltext 

Testicular cancer is one of the most common cancers affecting men between the ages of 15 and 44, yet when detected early it is highly treatable. Africa Melane is joined by CANSA Spokesperson, Lucy Balona, to discuss the warning signs, the importance of monthly self-examinations, and why early detection can save lives. They also unpack this year's Hollard Daredevil Run, with registrations now open, and how the iconic event is using a fun, bold campaign to get more men talking about their health and taking action. Early Breakfast with Africa Melane is 702’s and CapeTalk’s early morning talk show. Experienced broadcaster Africa Melane brings you the early morning news, sports, business, and interviews politicians and analysts to help make sense of the world. He also enjoys chatting to guests in the lifestyle sphere and the Arts. All the interviews are podcasted for you to catch-up and listen.Thank you for listening to this podcast from Early Breakfast with Africa Melane For more about the show click https://buff.ly/XHry7eQ and find all the catch-up podcasts here https://buff.ly/XJ10LBUListen live on weekdays between 04:00 and 06:00 (SA Time) to the Early Breakfast with Africa Melane broadcast on 702 https://buff.ly/gk3y0Kj and CapeTalk https://buff.ly/NnFM3NSubscribe to the 702 and CapeTalk daily and weekly newsletters https://buff.ly/v5mfetcFollow us on social media:702 on Facebook: https://www.facebook.com/TalkRadio702702 on TikTok: https://www.tiktok.com/@talkradio702702 on Instagram: https://www.instagram.com/talkradio702/702 on X: https://x.com/Radio702702 on YouTube: https://www.youtube.com/@radio702 CapeTalk on Facebook: https://www.facebook.com/CapeTalkCapeTalk on TikTok: https://www.tiktok.com/@capetalkCapeTalk on Instagram: https://www.instagram.com/CapeTalk on X: https://x.com/CapeTalkCapeTalk on YouTube: https://www.youtube.com/@CapeTalk567See omnystudio.com/listener for privacy information.

Primary care docs Kate Rowland, Mark Ebell, Henry Barry and Gary Ferenchick talk about 4 new studies: prevention of multimorbidity in people at high risk of diabetes, high-dose vitamin D in healthy older adults, whether screening for skin cancer reduces melanoma mortality, and tirzepatide withdrawal and weight maintenance .

A review of the national cervical cancer screening register has found widespread issues that could have led to undetected harm, while the public can't be assured the register is clinically safe. It found the register was launched in 2023 with limited functionality and several known issues, including incomplete data migration from the previous register. National Director, Prevention Screening, National Public Health Service, Alana Ewe-Snow spoke to Melissa Chan-Green.

Almost a million notifications didn't get sent to women eligible for cervical cancer screening, after a new register was set up in 2022. A Health New Zealand review into the national screening programme says it's not an effective safety net and made 48 recommendations for change. Dr Bev Lawton, who has been a driving force in women's health and improving access to cervical screening, spoke to Ingrid Hipkiss.

My name is Sally Block, the MJA's news and online editor.“The MJA acknowledges the Traditional Owners and Custodians of the land on which we live and work across Australia.  This podcast was recorded on the lands of the Wangal people. I pay my respects to their Elders past and present.”The lung cancer screening program was introduced in July last year, designed to help with early intervention for Australia's deadliest cancer. So how's it faring?To discuss this, our special guest today is Professor Fraser Brims who is a consultant respiratory physician at St Charles Gairdener Hospital and Curtin University in Perth.He has written a perspective for the MJA on the program calling for more investment so it can reach it's full potential. He joins me on this podcast.

Send us Fan MailEpisode 046: Men's Midlife Wake-Up Call: Metabolism, Movement, and Prostate ScreeningFor many men, the first signs of aging aren't gray hair—they're a growing waistline, slower recovery after workouts, rising blood pressure, and the realization that they don't feel as strong or energetic as they once did. In this episode, Dr. Angela sits down with Dr. John from Thrive Family Health to discuss why the 40s and 50s are often a turning point for men's health and how small, intentional changes can dramatically improve long-term health.Together, they explore how metabolism changes with age, why movement matters more than ever, and how sleep, nutrition, stress, and hormone health all work together to influence energy, strength, and overall well-being. They also discuss why physically demanding jobs don't always provide the type of exercise the body needs and how purposeful strength training, mobility work, and recovery can help prevent injury and maintain function.The conversation also emphasizes the importance of preventive care and cancer screening. Dr. Angela and Dr. John explain how prostate cancer screening has evolved, why establishing a baseline PSA around age 45 (or earlier for those with higher risk or a family history) can be valuable, and why urinary symptoms should never be ignored. They also review the role of colon cancer screening and how early detection has significantly improved outcomes for many cancers.Whether you're entering midlife yourself or encouraging someone you care about to prioritize their health, this episode is a reminder that aging doesn't have to mean declining health—and that the best time to take action is before symptoms become serious.In This EpisodeWhy many men delay seeking medical care until midlifeHow metabolism changes with age—and what you can do about itThe impact of sleep, stress, nutrition, and physical activity on long-term healthWhy physically demanding work isn't always enough to stay healthyThe importance of strength training, mobility, and injury preventionWhen changes in libido or erectile function may signal underlying cardiovascular diseaseCurrent recommendations for prostate cancer screening and PSA testingWhen to start colon cancer screening and why early detection saves livesWhy routine preventive care can help men stay healthy and active for decades to comeChapters00:00 – Men's Midlife Wake-Up Call: Metabolism, Movement & Aging Well09:18 – Cancer Screening, PSA Testing & PreventionSupport the showFollow me on Instagram @angelalifestylemd and don't forget to SUBSCRIBE to my podcast & SHARE this episode.

Most people don't think about cancer screening when they feel healthy — no symptoms, no warning signs, no reason to worry. That's exactly what made the following patient story so unexpected and important. In the final episode of the miniVHAN podcast's Cancer Screening and Prevention series, Mary Jo Wiggins shares how a routine colorectal screening led to a stage four cancer diagnosis — and why it may have saved her life.

People with a history of tobacco smoking are recommended to have screening CT for lung cancer, but many of them choose not to be screened. A new study looks at the ability of a blood test to discern who is … Can a blood test improve lung cancer screening? Elizabeth Tracey reports Read More »

Welcome to the Hot Topics podcast from NB Medical with Dr Neal Tucker. In this episode, we have three new pieces of research and a special interview later on discussing the recommendations of the National Screening Committee on prostate cancer screening in the UK.First up for research: nasal sprays versus the common cold. The BJGP reports on longer-term findings through this simple intervention. Can it help this age-old problem?Second, new kid on the block, orforglipron - could it replace SGLT2 inhibitors for management of type 2 diabetes?Third, home-based hypnotherapy. Can it help children struggling with functional abdominal pain or IBS? We have a RCT to tell us. Finally, our interview with Dr Liz Bancroft, consultant nurse in oncogentics research, and Natalia Norori, interim Head of Data and Evidence at Prostate Cancer UK join us to discuss the new recommendations from the National Screening Programme with targeted screening of men with BRCA2, why they made this recommendation and how this affects us in general practice, plus what we need to know for our patients about the government-backed trial, TRANSFORM.ReferencesProstate Cancer UK Information on NSC decisionProstate Cancer UK Health Professional NSC FAQsNational Screening Committee report on prostate cancer screeningBJGP Nasal sprays for the common coldLancet Nasal Sprays original paperLancet Orforglipron vs dapagliflozin and T2DMBJGP Hypnotherapy in children for abdo painNational Screening Committee report on prostate cancer screeningwww.nbmedical.com/podcast

Today we're talking about breast cancer. Here at ZOE, we know that health is deeply personal - and breast cancer risk is no different. Your likelihood of developing breast cancer is shaped by factors such as genetics, body composition, and lifestyle.  Understanding your individual risk is crucial because it helps determine when and how you should be screened - and in some cases, it could save your life. Today, I'm joined by Dr. Thais Aliabadi to explain why breast cancer screening shouldn't follow a one-size-fits-all approach, and how her own experience with cancer has influenced the way she thinks about prevention.

In this episode of Test Those Breasts, Jamie sits down with fellowship-trained breast radiologist, Navy veteran, and founder of MammoLink, Dr. Ryan Polselli, for an important conversation about the future of breast cancer screening, access, and education.Ryan shares how his frustration with the traditional screening model led him to create one of Florida's fastest-growing mobile breast imaging companies — bringing mammography directly to workplaces, schools, and communities to eliminate barriers and save lives.Together, Jamie and Ryan discuss:Why nearly 50% of eligible women skip annual mammogramsThe biggest barriers making breast cancer screening harder than it should beWhy mobile mammography alone is not enough — and what truly makes screening patient-centeredHow Mammolink is partnering with school districts and organizations to improve accessThe dangerous misinformation around mammograms “causing cancer”Why ultrasound should never replace mammographyThe truth about dense breasts and supplemental imagingThe concerning rise of breast cancer in younger women (ages 35–40)Whether it's time to reconsider the recommended age for screeningWhy annual screening matters — and what can happen when you delay, even by one yearThe insurance and policy implications of the new USPSTF biennial screening recommendationsThis conversation is packed with practical education, myth-busting, and a fresh perspective on how we can improve outcomes through earlier detection and better access.One of the biggest takeaways:Mammograms detect cancer. They do not cause it.And when paired with education and supplemental imaging when needed, they save lives.Connect with Dr. Ryan Polselli

Breast cancer screening isn't just about mammograms. It's about understanding your risk, asking the right questions, and knowing your options. In this episode, Jennifer sits down with Ashley Flurry, founder of Breast Imaging Matters Outreach, to discuss why breast health conversations should start earlier than many women realize. Ashley shares her personal story, clears up common misconceptions about screening, and explains how risk assessments can help women make informed decisions about their health. It's an honest, educational conversation designed to help women advocate for themselves and the people they love.

In a special edition of the This Week in Global Development podcast, Devex cofounder and Executive Vice President Alan Robbins sits down with Brazilian thoracic surgeon Dr. Ricardo Sales do Santos to discuss a revolutionary approach to tackling lung cancer in medically underserved communities in Brazil. As the most lethal form of cancer globally, lung cancer often goes undetected until its final stages, but Dr. Santos and the Bristol Myers Squibb Foundation are working to change that narrative through a combination of mobile technology and local capacity building. By bringing advanced CT scanning units directly into high-risk, low-income communities, they are catching tumors when they are small and potentially curable, fundamentally shifting the odds for thousands of patients. The conversation also touches on the logistical and cultural hurdles of delivering specialized oncology care to remote areas. Dr. Santos highlights the importance of “bringing the clinic to the patient,” utilizing mobile CT units and telemedicine to bridge the gap in healthcare access. Beyond the technology, the success of the program relies heavily on empowering local health workers and community members to recognize early cancer warning signs and overcome the stigma associated with a cancer diagnosis. This approach not only improves individual health outcomes but also strengthens the broader healthcare system, offering a scalable model for global health initiatives. To learn more about sustainable improvements in cancer care and get a compelling look at how local solutions can drive global change, listen to this special edition of This Week in Global Development. For more international development news, visit: http://www.devex.com Visit Strengthening Care Systems — a series raising awareness of the scale of the global lung cancer burden and the systems-level changes required to address it: https://pages.devex.com/strengtheningcaresystems.html

Michell Futrell is the Director of Lung Cancer Screening, Programs and Initiatives at the LUNGevity Foundation. Its mission is to close the gap of the 85% that do not receive an early detection screening. You should listen to this episode of The Mark Bishop Show. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

As you may have seen on social media recently, TV presenter Jeremy Clarkson spoke out on his experience of being diagnosed with prostate cancer.He encouraged his followers to get tested, stating the vital importance of prostate screening, encouraging followers not to be one of the "12,000 people, men, who die every year in the UK from prostate cancer".Sinn Féin TD Sean Crowe has had his own experience with prostate cancer over ten years ago, and joins Shane to discuss.

A clear, reassuring episode about the role of routine cancer screenings in improving outcomes. Learn which tests matter most and how early detection changes prognosis for patients and families.

In this episode of Keeping Abreast, Dr. Jenn Simmons responds to Peter Attia's breast cancer screening episode (#396). Attia asks the right question: why are 42,000 women still dying of breast cancer every year? But his answer, more mammograms and MRI on top, is exactly wrong. Dr. Jenn breaks down, study by study, why that 40-year approach has never moved the death toll.Forty-two thousand women a year. That number has not moved since mammography went mainstream in the 1980s. Detection rates are up, diagnoses are up, and the death toll has not changed. We have been finding more cancer, calling more women patients, and watching the same number of them die. If you have ever scheduled your annual mammogram believing it was the most protective thing you could do, this episode will reframe everything you thought you knew.What You'll LearnWhy the breast cancer death toll has not moved in 40 years, and why more screening is the reasonWhy DCIS is not cancer, why mammography invented it, and what happens to a woman the moment it gets labeled "stage zero"Why an aggressive tumor is aggressive from the day it forms, and why finding it earlier on a mammogram does not change what it does nextWhy mammography catches the cancers least likely to kill you, and routinely misses the ones that willWhat happened when researchers followed 89,835 women for 25 years and compared annual mammography to doing nothing, and why you have never heard about itWhat the Cochrane review found after analyzing every randomized mammography trial ever run, and why Peter Attia addressed it in one sentenceWhy the WISDOM trial, the most significant recent evidence in this space and the one study Attia never mentions, is an indictment of everything he arguedWhy there is no standard radiation dose for a mammogram, and why the woman next to you in the waiting room may have received ten times less than you didWhat the FDA has formally documented about gadolinium staying in the brain and bones for years, and why the women being told to get it every six months are the last women who shouldWhy insulin resistance, chronic inflammation, and toxic burden are among the most powerful drivers of breast cancer risk, and why Attia's episode contained zero mention of any of themResources MentionedPeter Attia, Episode 396 on breast cancer screening: peterattiamd.com/breastcancerscreeningDr. Robin Berzin, founder of Parsley HealthMiller AB, et al. Twenty five year follow-up of the Canadian National Breast Screening Study. BMJ. 2014;348:g366.Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013;(6):CD001877.Zahl PH, et al. Results of the Two-County trial are not compatible with official Swedish breast cancer statistics. Danish Medical Bulletin. 2006;53(4):438–440.Nyström L, et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359:909–19.Esserman LJ, et al. Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial. JAMA. 2026;335(9):763–774.FDA gadolinium-based contrast agent safety communications (2015, 2017, 2018), summarized in Fotenos A, FDA Pediatric Advisory Committee, Sept 2018.Kanda T, et al. High signal intensity in the dentate nucleus and globus pallidus and cumulative gadolinium dose. Radiology. 2014;270(3):834–841.Veenhuizen SGA, et al. Supplemental breast MRI for women with extremely dense breasts: DENSE trial. Radiology. 2021;299(2):278–286.Tabar L, et al. Reduction in mortality from breast cancer after mass screening with mammography. Lancet. 1985;325:829–32.To talk to a member of Dr. Jenn's team and learn more about working privately with Dr. Jenn visit: https://calendly.com/stephanie-1031/clarity-callTo get your copy of Dr. Jenn's book, The Smart Woman's Guide to Breast Cancer, visit: https://tinyurl.com/SmartWomansBreastCancerGuideTo purchase the auria breast cancer screening test go here https://auria.care/ and use the code DRJENN20 for 20% Off.Connect with Dr. Jenn:Website: https://www.jennsimmonsmd.com/Facebook: https://www.facebook.com/DrJennSimmonsInstagram: https://www.instagram.com/drjennsimmons/YouTube: https://www.youtube.com/@dr.jennsimmons

Preparing for a colonoscopy may not be anyone's favorite part of colorectal cancer screening, but proper colonoscopy prep is one of the most important factors in detecting precancerous polyps and colorectal cancer early. In this episode, Jacqueline Gaulin sits down with leading gastroenterologist Dr. Fola May to answer common questions about bowel preparation for colonoscopy. Why is colonoscopy prep necessary? What happens if the bowel isn't cleaned properly? Have preparation options improved over the years? And what can patients do to make the process easier? As a co-author of the latest U.S. Multi-Society Task Force recommendations on bowel preparation for colonoscopy, Dr. May explains how colonoscopy prep has evolved to become more effective and patient-friendly. She discusses lower-volume bowel prep options, updated dietary recommendations, and practical strategies to help patients achieve a high-quality prep and avoid repeat procedures. In this episode, you'll learn: ✅ Why bowel preparation is essential for an effective colonoscopy ✅ How poor prep can impact polyp and cancer detection ✅ Newer low-volume colonoscopy prep options ✅ Updated diet recommendations before a colonoscopy ✅ Tips for improving your colonoscopy prep experience ✅ How proper prep helps improve colorectal cancer screening outcomes Whether you're preparing for your first colonoscopy or looking for the latest guidance on bowel preparation, this episode provides expert insights to help you feel more confident and informed. This episode is brought to you in collaboration with the American College of Gastroenterology Patient Care Committee.   

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this episode, Peter explores the critical topic of breast cancer screening, examining why thousands of women continue to die from breast cancer each year despite the availability of effective screening tools. He explains the strengths and limitations of current screening strategies, reviews the recommendations from major medical organizations, and discusses why screening guidance can often seem confusing or contradictory. Peter outlines a practical framework for understanding breast cancer risk and personalizing screening decisions, including when to begin screening, how frequently to screen, and which imaging modalities may be most appropriate based on an individual's risk profile. Throughout the episode, he emphasizes that while population-based guidelines provide an important foundation, optimizing outcomes requires a more personalized approach aimed at helping women make informed screening decisions that can improve the chances of early detection and successful treatment. We discuss: Why women still die from breast cancer: the benefits of screening, the problem of under-screening, and the need for risk-based screening strategies [1:45]; Current screening recommendations, why they differ between organizations, and the importance of personalized screening decisions [6:30]; A framework for personalizing screening [8:45]; Assessing baseline breast cancer risk: genetics, family history, breast density, lifestyle factors, and the role of risk calculators in personalized screening [9:30]; Balancing cancer detection and false positives: how breast cancer risk influences screening intensity and imaging choices [17:45]; Mammography as the foundation of breast cancer screening: detecting ductal carcinoma in situ (DCIS) and the advantages of 3D versus 2D mammography [21:00]; MRI for high-risk women: the benefits of supplemental screening, abbreviated MRI, and the emerging role of contrast-enhanced mammography [23:00]; The role of ultrasound: supplemental cancer detection, diagnostic evaluation, and limitations compared with mammography and MRI [26:00]; Choosing the right breast cancer screening strategy: imaging modality selection, screening hierarchies, and the importance of imaging center quality [28:00]; How often should you screen for breast cancer? [30:15]; At what age should you start screening? [37:30]; Breast cancer in younger women: aggressive tumor biology, BRCA-related risk, breast density, and individualized decisions about when to begin screening [41:45]; Inflammatory breast cancer, the limitations of screening mammography for symptomatic disease, and the importance of promptly evaluating new breast symptoms in both women and men [44:45]; From risk assessment to personalized screening: a practical framework for reducing breast cancer mortality through earlier and more effective detection [46:30]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

Dr. Centor discusses the American College of Physicians guidance on breast cancer screening with Dr. Carolyn Crandall.

In this episode of Inside the Lab, Patricia Delgado and Liz Etkin-Kramer explore the evolving landscape of cervical cancer screening amid recent guideline updates emphasizing primary HPV testing, self-collection, and revised screening exit criteria. The conversation examines the challenges posed by HPV-negative cervical cancers and highlights the importance of close collaboration between pathology and OB-GYN teams when screening results, clinical findings, and patient presentation do not align neatly. Through a detailed case discussion, the guests describe how ongoing communication and iterative review between specialties ultimately leads to improved diagnostic accuracy in difficult cases, underscoring the value of interdisciplinary partnership in complex gynecologic cases.Key TakeawaysRecent cervical cancer screening updates are not yet fully harmonized across major professional organizations, creating a transitional landscape that clinicians and laboratories must navigate carefully.HPV-negative cervical lesions and cancers can present significant diagnostic challenges, particularly when standard screening results do not match clinical suspicion.Strong, iterative collaboration between OB-GYNs and pathologists can be critical for resolving complex cases and achieving accurate diagnoses, as illustrated by the discussion of lobular endocervical glandular hyperplasia.

Kevin Boston-Hill speaks with Naismith Basketball Hall of Famer Nancy Lieberman, and Chief Philanthropy Officer of the Prostate Cancer Foundation, Lori Tessel, about how important it is to have prostate cancer screening. Those who get screened and detect the cancer early have a 99% survival rate.

The heated debate on prostate cancer screening boils down to one question: should men be routinely screened? Two recent position statements from the UK's national screening committee published in the BMJ show that screening decisions are steeped in complexity.  The benefits of screening may be easier to grasp, but the harms of overdiagnosis and overtreatment are given less attention. Can we close the divide between the public and academic discourse?   Guest: Sian Taylor-Phillips is professor of population health at the University of Warwick and a member of the UK national screening committee.   Further Reading: UK National Screening Committee position statement on surrogate outcomes in cancer screening trials Prostate cancer screening: Committee rejects calls for mass testing programme despite pressure More interviews from the BMJ on our Youtube channel.

Interview with Joachim Hübner, MD, SJD, and Alexander Katalinic, MD, authors of Population Skin Cancer Screening and Melanoma Mortality Rates. Hosted by Adewole S. Adamson, MD, MPP. Related Content: Population Skin Cancer Screening and Melanoma Mortality Rates

Interview with Joachim Hübner, MD, SJD, and Alexander Katalinic, MD, authors of Population Skin Cancer Screening and Melanoma Mortality Rates. Hosted by Adewole S. Adamson, MD, MPP. Related Content: Population Skin Cancer Screening and Melanoma Mortality Rates

Program notes:0:35 Cell-free DNA screening for cancer and diagnosis delays1:35 Populations-based screening2:35 24 different companies offer liquid biopsy3:01 Can we prevent chronic back pain after acute back pain?4:01 Impact score on chronic back pain5:01 Real-world setting lacks impact6:01 Primary care role7:01 Individual should assess their own back pain7:25 Resistance training and mortality8:25 Most benefit with aerobic and resistance training9:20 GLP1 and knee arthroplasty10:20 Using a GLP1 reduced risk of knee arthroplasty11:23 Can't imagine using them solely for this purpose12:25 End

On today's episode, we sit down with Dr. James Cates talking all things men's health in honor of Men's Health Month. Starting off with his medical background and misconceptions around men's health. They also touch on the use of GLP-1 medications and changes in weight loss. As well as supplementing water and protein for proper weight loss without the medication. From GLP-!s to Cancer Screenings and everything in between, men's health is more important than ever to keep track of and discuss. Listen To The Local Matters Podcast Today! News Talk 94.1

Health care policy plays a critical role in who gets screened for cancer and who can afford it. In the miniVHAN with us is, Maddie Michael of the American Cancer Society Cancer Action Network who shares how advocacy, legislation and community voices shape access to cancer care and improve outcomes.

The American Cancer Society (ACS) recently updated its colorectal cancer screening recommendations, adding new stool-based and blood-based screening options. What's changed in the new American Cancer Society screening recommendations • New stool DNA and stool RNA screening tests • The role of blood-based cancer screening tests • Why colonoscopy remains the gold standard • Why a follow-up colonoscopy is still needed after a positive screening test • Screening recommendations for adults ages 45–75 • The rise in colorectal cancer among younger adults and what patients should know The most important takeaway? Colorectal cancer is highly preventable, and the best screening test is the one that gets completed. This episode is intended for educational purposes only and should not replace medical advice from your healthcare provider.  

Police apologise for arresting a dying teen, stabbed with a ceremonial knife, after his killer's 'wicked' racism lie. Dame Helen Mirren is verbally abused in the street by a pro-Palestinian activist and Health officials reject calls for mass screening for prostate cancer by rationing it to only "a few thousand" men.

Taylor Dayne brings her good to our 250th episode. She's a Grammy-nominated, American Music Award-winning vocal powerhouse who has conquered the Top 20 on the Billboard Top 100 chart 17 times landing 7 times in the Top 10.Taylor's unbelievable career ascent has taken her from sold-out rock concerts to starring on Broadway in Aida to the semi-finals of the Masked Singer. In 2022, an unexpected diagnosis of colon cancer did little to slow her down and made her an advocate for promoting early detection and regular cancer screenings. We talk with Taylor about what drives her, how she chooses her songs (or if they choose her), and exactly what was that whole thing with Tig Notaro even about. This is a reunion of sorts as World Gone Good host, Steve, originally met Taylor at a mutual friend's last-minute cocktail hour in Santa Barbara. Funny how things work out, ain't it? Get ready to 'Tell It To My Heart' with the amazing Taylor Dayne here with us to celebrate episode #250! __________________ June 13 and July 12 - grab your seat to SLIDESHOW: IN COLOR! now playing in London. It's the live storytelling show the Los Angeles Times declares, "Downright magical, uncomfortable and shockingly honest!" and Theatreland Adventures London cheers, "FOUR STARS - This is unlike anything I've seen before, a warm, engaging, and memorable evening!" Tickets & Info: https://www.citizenticket.com/events/etcetera-theatre/slideshow-in-color/ Pre-Order CUPID'S CURSE - the fourth book in Steve's series THE DOG WALKING DETECTIVES MYSTERIES and catch up on the rest: https://www.barnesandnoble.com/s/%22Steven+J+Silverman%22?Ntk=Publisher&Ns.

Editor's Summary by Preeti Malani, MD, MSJ, and Tracy Lieu, MD, MPH, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from May 16-22, 2026.

This clip comes from Dr. Raj's series with My Care Friends. Watch the video here: https://www.youtube.com/watch?v=ULrG2LLI9Ww About Dr. Raj Dr. Raj Dasgupta is an ABIM Quadruple board-certified physician specializing in internal medicine, pulmonology, critical care, and sleep medicine. He is currently the Associate Program Director of Internal Medicine Residency at Huntington Health in Pasadena, California and an Associate Professor of Clinical Medicine for the University of California, Riverside School of Medicine (UCR). He previously practiced at the University of Southern California, where he is an associate professor of clinical medicine, assistant program director of the Internal Medicine Residency Program, and the associate program director of the Sleep Medicine Fellowship. Dr. Dasgupta is an active clinical researcher and has been teaching around the world for more than 20 years. More from Dr. Raj The Dr. Raj Podcast Dr. Raj on Twitter Dr. Raj on Instagram Want more board review content? USMLE Step 1 Ad-Free Bundle Crush Step 1 Step 2 Secrets Beyond the Pearls The Dr. Raj Podcast Beyond the Pearls Premium USMLE Step 3 Review MedPrepTGo Step 1 Questions MedPrepTGo Step 2 Questions Follow MedPrepToGo https://medpreptogo.com https://www.instagram.com/medpreptogo/ https://www.linkedin.com/company/medpreptogo/ https://www.facebook.com/MedPrepToGo/ https://www.youtube.com/@MedPrepToGo Learn more about your ad choices. Visit megaphone.fm/adchoices

Grace is joined by Boston City Councilor Erin Murphy to discuss Durkan killing the firefighter cancer screening vote. Then, Grace found a new game called "Are You A Fascist?".  Visit the Howie Carr Radio Network website to access columns, podcasts, and other exclusive content.

What if the mammogram your doctor relies on is actually doing more harm than good, and a better option already exists? Dr. Cara Fuhrman, naturopathic doctor, Medical Director of Longevity RX, and daughter of nutritional science pioneer Dr. Joel Fuhrman, joins Integrative Cancer Solutions to break down the serious limitations of routine mammography, including staggering rates of overdiagnosis and overtreatment, and makes the case for QT Imaging as a radiation-free, far more accurate alternative. The conversation covers the three hormones silently fueling cancer growth, how everyday foods like white rice and animal protein accelerate tumor progression, and the anti-cancer power of cruciferous vegetables, flaxseeds, and raw garlic. If you want a more informed, proactive approach to breast cancer prevention, this episode delivers what your doctor may never tell you. Key Takeaways: 0:00 Introduction 0:32 Growing up with Dr. Joel Fuhrman and the nutritarian legacy 6:02 Layering herbs technology and nutrition to stop cancer 10:02 Mammogram overdiagnosis is harming more people than it helps 17:07 QT Imaging the radiation-free alternative to mammography 23:07 Why biopsies are overused and what to do instead 28:44 The three hormones silently fueling cancer growth 33:19 GBOMBS flaxseeds and garlic as everyday cancer medicine Resources: Dr. Cara's Instagram - https://www.instagram.com/drcarafuhrman/ Longevity RX -https://trylongevityrx.com/ Dr. Joel Fuhrman - https://www.drfuhrman.com Nordic Cochrane Centre - https://www.cochrane.org/ QT Imaging - https://www.qtimaging.com TerraSoul Superfoods - https://www.terrasoul.com Medical Disclaimer: This content is for educational purposes only and is not intended to diagnose, treat, cure, or replace professional medical advice. Always consult your physician or qualified healthcare provider regarding any medical condition or treatment decisions. ____________________________________RESOURCES FROM DR. KARLFELDT:

Cancer screenings can save lives, but the right screening plan can change as we age. In this episode of The University of Kansas Health System Open Mics, Dr. Steve Stites talks with geriatric medicine specialist Dr. Jessica Kalender-Rich and clinical oncologist Dr. Nina Mathew about cancer screenings for older adults and how seniors can make informed decisions about early detection. The conversation covers common screenings such as colonoscopy, mammograms, prostate cancer screening, lung cancer screening and skin cancer checks. The doctors also discuss why some screenings stop at a certain age, how health status and personal risk affect recommendations, and how patients can weigh the benefits and risks of routine cancer screening. They also look at newer options, including blood-based multi-cancer early detection tests, mail-in colon cancer screening, and mobile cancer screening programs designed to reach rural communities.

We bring back the biggest takeaways from the ACOG ACSM, then move fast through the newest guidance and the newest hype shaping real OBGYN care. We focus on what the evidence actually supports, where practice still lags behind, and how “labels” can quietly push patients toward harm.• conference highlights including rural OBGYN access and what gets attention on the exhibit floor • vitamin K shot refusal trends and why late bleeding still matters weeks after birth • 2026 ACOG cervical cancer screening changes with primary HPV testing preferred for ages 30 to 65 • self-collected HPV screening and the systems needed to keep follow-up safe • why annual Pap testing and cytology-only strategies increase overdiagnosis and can miss HPV risk • postmenopausal bleeding workup shifting toward ultrasound plus endometrial biopsy up front • large baby induction data and why outcomes can worsen without neonatal benefit • third-trimester ultrasound screening performance and the real-world labeling effect • early proof-of-concept therapy for preeclampsia targeting sFlt1 removal to prolong pregnancy • hysterectomy duration and route as drivers of venous thromboembolism risk • laboring down claims from retrospective reports versus randomized trial findings • debunking physiologic third stage claims and reaffirming active management to prevent hemorrhage Be sure to check out thinkingaboutobgyn.com for more information, and be sure to follow us on Instagram.0:00 ACOG Meeting Takeaways And Rural Access3:58 Vitamin K Refusal And Newborn Bleeding6:37 Cervical Screening Moves Toward HPV14:48 Postmenopausal Bleeding Now Needs Biopsy20:00 Tylenol Data And Macrosomia Induction28:34 Ultrasound Labeling Effect And Liability Fears37:29 Removing sFlt1 To Buy Time40:14 Longer Hysterectomy Surgeries Raise VTE Risk42:14 Laboring Down Claims Versus RCT Reality49:59 Counseling Fatigue Without Ignoring Risk54:21 Third Stage Myths And Hemorrhage Prevention58:42 Evidence Literacy And Closing NotesFollow us on Instagram @thinkingaboutobgyn.

Early colorectal cancer usually causes no symptoms, which means the only way to catch it at a truly curable stage—or even prevent it altogether—is through regular screening, especially colonoscopy. During a colonoscopy, doctors can not only find cancers earlier, when treatment is more effective and survival rates are much higher, but also remove precancerous polyps on the spot, stopping many cancers before they ever form. National guidelines now recommend that average‑risk adults begin colorectal cancer screening at age 45 and continue at regular intervals, using colonoscopy every 10 years or other approved tests, because this simple step has been shown to significantly lower both the incidence of colorectal cancer and deaths from the disease.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this episode, Peter takes a deep dive into colorectal cancer (CRC) screening, explaining why it is one of the most preventable cancers and why getting screening right can have life-saving implications. He walks through how colorectal cancer develops and why it is uniquely well-suited to early detection and prevention, with a particular emphasis on the dual role of colonoscopy as both a diagnostic and therapeutic tool. Peter also examines the concerning rise in early-onset CRC among younger adults, highlighting why awareness and timely screening matter more than ever. The episode provides a practical guide to preparing for and evaluating the quality of a colonoscopy, including how to think about appropriate screening intervals and the real risks and tradeoffs involved. Finally, Peter explores the expanding landscape of non-invasive screening options, offering clear insight into what these alternatives can and cannot do so listeners can make informed decisions about their care at any age. We discuss: CRC statistics and goals for this episode [1:00]; Colorectal cancer development: polyp progression, risk types, and the window for prevention [4:00]; Why colorectal cancer is uniquely screenable: direct visualization and the dual role of colonoscopy [6:30]; Colonoscopy effectiveness: prevention through polyp removal and interpreting the NordICC trial data [8:15]; Rising colorectal cancer in younger adults: trends, possible causes, and the case for earlier screening [12:15]; Colonoscopy preparation: why bowel prep matters and how newer options improve the experience [16:45]; Colonoscopy quality, polyp miss rates, and personalized screening intervals [20:00]; Colonoscopy risks versus colorectal cancer risk: understanding the true risk-benefit tradeoff [29:30]; Non-invasive screening options for CRC: benefits, limitations, and their role alongside colonoscopy [37:00]; Colorectal cancer prevention principles: why screening matters and the role of colonoscopy [39:30]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

Drs. Wierda and O'Brien discuss how fixed-duration venetoclax-based therapy can match continuous BTK inhibitor treatment in CLL while offering deep remissions and time off therapy. They also explore promising real-world CAR T-cell (liso-cel) results and stress the growing importance of vaccination and cancer screening as CLL patients live longer.

(From our Instagram Video Post): A very quick recap of the brand new ACOG Cervcial Caner Screening Update from April 24, 2026.

In episode 621, Tina, James and Mike K talk about the evidence around whole-body MRIs. We discuss how many abnormalities are found, how many cancers are actually found, and finally the lost opportunity costs. You need to know these numbers to talk to your patients about the value or lack thereof of doing this test. […]

In this episode, Alyssa Aberle shares her powerful personal journey through a patient diagnosis, surgery, and tongue reconstruction, offering a perspective that deeply resonates with dental professionals. The conversation emphasizes the critical role hygienists play in early detection of oral cancer and why cutting corners is never an option when it comes to patient care.   Alyssa, along with David and Jessica, dives into practical strategies for oral cancer screenings, including how to communicate findings with confidence and compassion. They also discuss when and how to refer patients to specialists, ensuring the best possible outcomes. A key highlight is the discussion around effective screening scripts and the importance of the 10–14 day rule in monitoring suspicious lesions.   What We Talked About:   Alyssa's personal experience with her patients diagnosis, surgery, and tongue reconstruction   The responsibility of dental professionals to thoroughly screen for oral cancer   Why you should never cut corners during exams   How to confidently refer patients and choose the right specialist   Verbiage and scripts that build trust during oral cancer screenings   Understanding and applying the 10–14 day rule   Call to Action: This episode is designed to empower dental hygienists to take ownership of their role in patient care. By listening, you'll gain the confidence, language, and clinical mindset needed to perform thorough screenings and advocate for your patients' health.   Resources and Links: Connect with Alyssa: linktr.ee/alyssardh alyssa.aberle@gmail.com  

What if the moment women stop seeing their gynecologist is exactly when their cervical cancer risk matters most? Nenrot S. Gopep, a physician and public health researcher, joins the show to discuss her KevinMD article, "Menopause and the drop in cervical cancer screening." Her research found that postmenopausal women are 24 percent less likely to receive a Pap smear compared to premenopausal women, even after controlling for insurance, age, and socioeconomic status. You will hear why the persistent myth that cervical cancer is only a concern for sexually active women is keeping older patients from getting screened, and why HPV can lie dormant for years before developing into cancer. Gopep explains how the shift away from gynecologists after menopause places greater responsibility on primary care physicians to continue screening through age 65. She also discusses the expanded availability of the HPV vaccine, what Australia's elimination of cervical cancer teaches us about what is possible, and the specific questions patients should be asking their doctors about screening and vaccination. If you or someone you care about has put off cervical cancer screening after menopause, this episode could change that decision. Partner with me on the KevinMD platform. With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Whether you need a sponsored article, email campaign, video interview, or a spot right here on the podcast, I offer the trusted space your brand deserves to be heard. Let's work together to tell your story. PARTNER WITH KEVINMD → https://kevinmd.com/influencer SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this episode, Peter takes a deep dive into prostate cancer screening, explaining why advanced and metastatic diagnoses continue to rise despite the availability of screening tools, and what can be done to reverse this trend. He breaks down what PSA actually measures and why it is far more informative when tracked over time rather than interpreted as a single value, and he explores how tools like MRI, PSA density, PSA velocity, and improved biopsy techniques can both reduce unnecessary procedures and improve the detection of aggressive cancers. Peter also discusses the role of active surveillance in avoiding overtreatment for low-risk cases, examines the flawed evidence that has historically been used to argue against PSA screening, and highlights how medications like finasteride can suppress PSA levels and potentially mask warning signs if not properly accounted for. Ultimately, he makes a compelling case for the importance of regular PSA testing as a key strategy in the effort to eliminate prostate cancer mortality. We discuss: The failure of current prostate cancer screening guidelines, and the rise in advanced disease despite available tools [2:30]; PSA screening fundamentals: benefits, harms, and the guideline shift driven by overdiagnosis concerns [5:30]; The impact of reduced PSA screening: rising rates of late-stage prostate cancer and worsening population-level outcomes [12:00]; How modern screening practices use PSA trends, MRI, and new imaging advances to improve accuracy and reduce unnecessary procedures [15:00]; Advances in prostate biopsy: transperineal approach improves safety and cancer detection [23:00]; Reducing overtreatment: Gleason scoring and active surveillance in modern prostate cancer care [25:30]; Reevaluating PSA screening guidelines: how flaws in the PLCO trial undermine the evidence used to argue against PSA screening [29:45]; Prostate cancer screening today: improved tools, flawed guidelines, and preventable mortality [33:45]; How finasteride and similar drugs suppress PSA levels and can lead to missed or delayed prostate cancer diagnoses if not properly accounted for [38:00]; The optimistic future of prostate cancer: modern screening advances and the potential to reduce mortality [43:15]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube